Adobe. And were off to the races without any real worry about last minute status of darn tax bill which is looking more and more likely that it will become law next thing you know, the dow rockets 143 points nasdaq,. 9 . Nasdaq pole vaults up 1. 17 . It is easy, isnt it look, we dont even know what is going to happen in washington. But as i told you last night, were in the torpedos full speed ahead moment i am telling you, its underrated by everybody. Corporate earnings witness the pin action from costco and adobe so while the specter of washington haunts the market bad, they cant stop the averages from going higher will it continue since earnings are really in charge here despite you think it may be the tax cut, i went over the last day cut it, raise it it doesnt matter. What matters is earnings lets go right to next weeks game plan. The big competition in stocks is bonds. Let me put this scene setter here obviously on monday we want to see what happens to that tax bill we also get so
Always is a dumb idea. Youre watching Market Makers on Bloomberg Television. Thursday in new york city, i am Erik Schatzker. I am stephanie ruhle. How do you feel . I feel great. Im not sure how i feel. These are the top business stories from around the world. Barclays will cut 7000 jobs in its investment bank, about one fourth of the total market. Trying tonkins is reduce his dependence on fixed income, which has been its biggest source of revenue. A big jump in homes being sold for cash according to the tracks 43 according realty tracks, were all cash in the first quarter. Mortgage lending has plummeted because rates have been rising and lending requirements have become stiffer. Macdonalds best month, samestore sales were up 1. 2 . Mcdonalds has been struggling to attract consumers because of growing competition like talk about like taco bell. There is a Consumer Confidence problem. Show deal ora game no deal, top executives from comcast and Time Warner Cable are back on capitol hill
Chips to Technology Stocks grabbed investors attention. All that and more tonight on nightly Business Report for monday, april 28th. Good evening, everyone. 100 billion. Thats what pfizer is offering to pay for astrazeneca. This is the Second Time Around pfizer is pushing for a deal with its british rival. Investors are cheering. Sending the dow soaring. Shares of pfizer shot up more than 4 by far the biggest gainer in the dow and astrazeneca jumped 12 . While the pharmaceutical deal may be huge its not a done deal. Astrazeneca has already rejected the offer and an earlier approach from pfizer saying the 100 billion cash and stock offer is too low and that it undervalues the company. We took a look at what combining these two companies mean to the pharmaceutical industry and whats at stake for pfizer and astrazeneca. Its the kind of deal that doesnt come around too often. 14 years ago pfizer paid 85 billion to buy warner lambert. That was the Biggest Health care combination ever. And s
Chips to Technology Stocks grabbed investors attention. All that and more tonight on nightly Business Report for monday, april 28th. Good evening, everyone. 100 billion. Thats what pfizer is offering to pay for astrazeneca. This is the Second Time Around pfizer is pushing for a deal with its british rival. Investors are cheering. Sending the dow soaring. Shares of pfizer shot up more than 4 by far the biggest gainer in the dow and astrazeneca jumped 12 . While the pharmaceutical deal may be huge its not a done deal. Astrazeneca has already rejected the offer and an earlier approach from pfizer saying the 100 billion cash and stock offer is too low and that it undervalues the company. We took a look at what combining these two companies mean to the pharmaceutical industry and whats at stake for pfizer and astrazeneca. Its the kind of deal that doesnt come around too often. 14 years ago pfizer paid 85 billion to buy warner lambert. That was the Biggest Health care combination ever. And s
Grabbed investors attention. All that and more tonight on nightly Business Report for monday, april 28th. Good evening, everyone. 100 billion. Thats what pfizer is offering to pay for astrazeneca. This is the Second Time Around pfizer is pushing for a deal with its british rival. Investors are cheering. Sending the dow soaring. Shares of pfizer shot up more than 4 by far the biggest gainer in the dow and astrazeneca jumped 12 . While the pharmaceutical deal may be huge its not a done deal. Astrazeneca has already rejected the offer and an earlier approach from pfizer saying the 100 billion cash and stock offer is too low and that it undervalues the company. We took a look at what combining these two companies mean to the pharmaceutical industry and whats at stake for pfizer and astrazeneca. Its the kind of deal that doesnt come around too often. 14 years ago pfizer paid 85 billion to buy warner lambert. That was the Biggest Health care combination ever. And since the recession theres b